DUBLIN--(BUSINESS WIRE )--The "Growth Opportunities in Synthetic Biology, Logic Gated Therapies, Rapid Molecular Diagnostics and Peptide Synthesis Platforms" report has been added to ResearchAndMarkets.com's offering.

This report focuses on synthetic biology innovations around low cost gene synthesis and deployment of gene circuits for drug discovery and in therapies. Cell and gene therapies using logic gated circuits, along with early stage developers of gene circuits for drug discovery applications are covered.

In addition advanced peptide design platforms and high throughput DNA synthesis platform has been covered. A rapid and sensitive molecular diagnostic for scalable Covid-19 testing, which can be adapted at PoC has also been discussed.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Innovations in Synthetic Biology and Various Therapies

For more information about this report visit https://www.researchandmarkets.com/r/zdhlg0

ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900